Gregory A. Odle Sells 5,359 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) insider Gregory A. Odle sold 5,359 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $133,224.74. Following the sale, the insider now owns 148,788 shares in the company, valued at $3,698,869.68. The trade was a 3.48 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

OrthoPediatrics Price Performance

OrthoPediatrics stock opened at $25.15 on Thursday. The business’s 50-day simple moving average is $24.79 and its 200 day simple moving average is $25.53. The stock has a market cap of $610.82 million, a price-to-earnings ratio of -20.45 and a beta of 1.22. OrthoPediatrics Corp. has a 12-month low of $21.02 and a 12-month high of $35.99. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings results on Tuesday, March 4th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.04. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. The business had revenue of $52.67 million for the quarter, compared to analysts’ expectations of $51.16 million. During the same quarter last year, the business earned ($0.23) earnings per share. As a group, research analysts anticipate that OrthoPediatrics Corp. will post -0.93 earnings per share for the current year.

Hedge Funds Weigh In On OrthoPediatrics

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in KIDS. Quarry LP bought a new position in OrthoPediatrics during the third quarter worth about $25,000. R Squared Ltd bought a new position in OrthoPediatrics during the fourth quarter worth about $48,000. KLP Kapitalforvaltning AS bought a new position in OrthoPediatrics during the fourth quarter worth about $79,000. BNP Paribas Financial Markets boosted its holdings in OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock worth $94,000 after buying an additional 1,929 shares during the last quarter. Finally, Quantbot Technologies LP boosted its holdings in OrthoPediatrics by 42.2% during the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company’s stock worth $157,000 after buying an additional 1,712 shares during the last quarter. Institutional investors own 69.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on KIDS shares. Truist Financial decreased their target price on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Needham & Company LLC restated a “buy” rating and set a $42.00 target price on shares of OrthoPediatrics in a report on Wednesday, March 5th. Finally, Stifel Nicolaus decreased their target price on OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating on the stock in a report on Wednesday, March 5th.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.